MedTrace Logo

Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population

NCT03035578 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2020-02-25

No results posted yet for this study

Summary

This research aims to study what the baby's body does with morphine and how morphine works in the baby's body. One hundred newborn babies will be enrolled in this study. With a better understanding of the drug doctors and nurses will have more information and better administer the drug in case of pain, stress or discomfort.

Conditions

Interventions

DRUG

Morphine

Sampling blood for development of Morphine Pharmacokinetic/Pharmacodynamic Model for Neonatal Population

DRUG

Morphine

Sampling saliva for development of Morphine Pharmacokinetic/Pharmacodynamic Model for Neonatal Population

Sponsors & Collaborators

  • The Hospital for Sick Children

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-06-01
Completion
2019-06-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03035578 on ClinicalTrials.gov